Proprietary AI analyst is now available

Nahdi Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nahdi Medical and similar public comparables like Sugi Holdings, Clicks Group, Jointown Pharmaceutical, COSMOS Pharmaceutical and more.

Nahdi Medical Overview

About Nahdi Medical

Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments Front Shop and Pharma.


Founded

1986

HQ

Saudi Arabia

Employees

N/A

Website

nahdi.sa

Sectors

Financials (LTM)

Revenue: $3B
EBITDA: $464M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nahdi Medical Financials

Nahdi Medical reported last 12-month revenue of $3B and EBITDA of $464M.

In the same LTM period, Nahdi Medical generated $1B in gross profit, $464M in EBITDA, and $223M in net income.

Revenue (LTM)


Nahdi Medical P&L

In the most recent fiscal year, Nahdi Medical reported revenue of $3B and EBITDA of $468M.

Nahdi Medical is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 17%, and net margin of 8%.

See analyst estimates for Nahdi Medical
LTMLast FY202320242025202620272028
Revenue$3B$3B$2B$3B$3B
Gross Profit$1B$1B$955M$957M$1B
Gross Margin37%37%40%37%37%
EBITDA$464M$468M$437M$437M$468M
EBITDA Margin17%17%19%17%17%
EBIT Margin9%9%11%9%9%
Net Profit$223M$225M$242M$222M$225M
Net Margin8%8%10%9%8%

Financial data powered by Morningstar, Inc.

Nahdi Medical Stock Performance

Nahdi Medical has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Nahdi Medical's stock price is $25.53.

Nahdi Medical share price decreased by 3.1% in the last 30 days, and by 25.0% in the last year.

Nahdi Medical has an EPS (earnings per share) of $1.73.

See more trading valuation data for Nahdi Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B-0.0%-3.1%-9.0%-25.0%$1.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nahdi Medical Valuation Multiples

Nahdi Medical trades at 1.2x EV/Revenue multiple, and 7.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Nahdi Medical

EV / Revenue (LTM)


Nahdi Medical Financial Valuation Multiples

As of June 13, 2026, Nahdi Medical has market cap of $3B and EV of $3B.

Nahdi Medical has a P/E ratio of 14.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.3x1.5x1.4x1.3x
EV/EBITDA7.5x7.4x7.9x7.9x7.4x
EV/EBIT13.9x14.0x13.4x14.8x14.0x
EV/Gross Profit3.3x3.4x3.6x3.6x3.4x
P/E14.9x14.7x13.7x14.9x14.7x
EV/FCF-17.9x13.0x11.6x17.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nahdi Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nahdi Medical Margins & Growth Rates

Nahdi Medical grew revenue by 6% and EBITDA by 1% in the last fiscal year.

In the most recent fiscal year, Nahdi Medical reported gross margin of 37%, EBITDA margin of 17%, and net margin of 8%.

See estimated margins and future growth rates for Nahdi Medical

Nahdi Medical Margins

Last FY202420252026202720282029
Gross Margin37%37%37%37%
EBITDA Margin17%17%17%16%
EBIT Margin9%9%9%9%
Net Margin8%9%8%8%
FCF Margin7%12%7%-

Nahdi Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%8%8%6%
Gross Profit Growth6%0%8%6%
EBITDA Growth1%(0%)7%1%
EBIT Growth2%(10%)6%2%
Net Profit Growth(0%)(8%)1%(0%)
FCF Growth-12%(35%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Nahdi Medical Operational KPIs

Nahdi Medical's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nahdi Medical's Rule of X is 30% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Nahdi Medical
LTMLast FY202320242025202620272028
Rule of 4024%22%---
Bessemer Rule of X35%30%---
S&M Expenses to Revenue24%24%5%4%4%
G&A Expenses to Revenue4%4%1%1%1%
Opex to Revenue-28%29%28%28%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nahdi Medical Competitors

Nahdi Medical competitors include Sugi Holdings, Clicks Group, Jointown Pharmaceutical, COSMOS Pharmaceutical, DaShenLin Pharmaceutical, Sundrug, CR Pharmaceutical, Yifeng Pharmacy, Fragua and Ebos Group.

Most Nahdi Medical public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Sugi Holdings0.5x0.5x7.4x7.2x
Clicks Group1.2x1.2x8.7x8.5x
Jointown Pharmaceutical0.2x0.2x4.9x5.4x
COSMOS Pharmaceutical0.5x0.5x7.4x7.6x
DaShenLin Pharmaceutical0.6x0.6x5.1x5.2x
Sundrug0.5x0.5x7.0x6.3x
CR Pharmaceutical0.3x0.3x4.0x4.1x
Yifeng Pharmacy0.9x0.8x4.9x4.9x

This data is available for Pro users. Sign up to see all Nahdi Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nahdi Medical

When was Nahdi Medical founded?Nahdi Medical was founded in 1986.
Where is Nahdi Medical headquartered?Nahdi Medical is headquartered in Saudi Arabia.
Who is the CEO of Nahdi Medical?Nahdi Medical's CEO is Yasser Ghulam Abdulaziz Joharji.
Is Nahdi Medical publicly listed?Yes, Nahdi Medical is a public company listed on Tadawul.
What is the stock symbol of Nahdi Medical?Nahdi Medical trades under 4164 ticker.
When did Nahdi Medical go public?Nahdi Medical went public in 2022.
Who are competitors of Nahdi Medical?Nahdi Medical main competitors include Sugi Holdings, Clicks Group, Jointown Pharmaceutical, COSMOS Pharmaceutical, DaShenLin Pharmaceutical, Sundrug, CR Pharmaceutical, Yifeng Pharmacy, Fragua, Ebos Group.
What is the current market cap of Nahdi Medical?Nahdi Medical's current market cap is $3B.
What is the current revenue of Nahdi Medical?Nahdi Medical's last 12 months revenue is $3B.
What is the current revenue growth of Nahdi Medical?Nahdi Medical revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Nahdi Medical?Current revenue multiple of Nahdi Medical is 1.2x.
What is the current EBITDA of Nahdi Medical?Nahdi Medical's last 12 months EBITDA is $464M.
What is Nahdi Medical's EBITDA margin?Nahdi Medical's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of Nahdi Medical?Current EBITDA multiple of Nahdi Medical is 7.5x.
How many companies Nahdi Medical has acquired to date?Nahdi Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nahdi Medical has invested to date?Nahdi Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nahdi Medical

Lists including Nahdi Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial